tirzepatide mastery course
Unit 10 of 12

Dosing & Administration

approved titration schedules, community-reported protocols, and practical administration guidance

From Label to Practice

Tirzepatide is approved at three maintenance doses -- 5mg, 10mg, and 15mg -- administered once weekly by subcutaneous injection. The approved titration starts at 2.5mg for four weeks, then escalates in 2.5mg increments every four weeks. Outside of clinical settings, community-reported protocols vary widely. This unit covers the FDA-approved schedule, what community users report about titration speed, reconstitution of lyophilized peptide, stacking with other compounds, and cycling strategies.

The following content documents community-reported tirzepatide protocols for educational purposes only. Nothing here constitutes medical advice. No dosing regimen described has been validated by clinical trials for every use case discussed, and product quality from unregulated sources varies and represents a significant risk factor. Consult a qualified healthcare provider before making any decisions about your health.

Dosing Calculator

Explore tirzepatide's approved titration schedule and see how different dose levels compare.

interactive dosing calculator
2.5 mg
sub-therapeutic starting dose designed solely for gi tract acclimation
4 weeks
escalation interval between each 2.5 mg dose increase
15 mg
maximum approved dose, reached at week 21 of the standard titration
1.2-1.6
g/kg/day protein intake recommended to preserve lean mass during treatment
community protocols lack clinical validation. Community-reported dosing modifications (microdosing, extended titration, dose step-down for maintenance) have no clinical trial support. The approved 4-week titration schedule was optimized through formal dose-finding studies. Any modifications should be made under physician guidance.

key terms for this unit

T titration dosing strategy
The process of gradually increasing drug dose over time to reach a therapeutic level while minimizing side effects. Tirzepatide uses 2.5 mg increments every 4 weeks from 2.5 mg to a maximum of 15 mg.
L lyophilized powder formulation
Freeze-dried peptide powder that requires reconstitution with bacteriostatic water before injection. The form used by compounding pharmacies during the tirzepatide shortage (2022-2025).
B bacteriostatic water reconstitution solvent
Sterile water containing 0.9% benzyl alcohol as a preservative. Used to reconstitute lyophilized peptide vials. A 30 mg vial reconstituted with 3 ml creates a 10 mg/ml concentration.
S steady state pharmacokinetics
The point at which drug input equals drug elimination, producing stable plasma concentrations. Reached after approximately 4 weeks (4 doses) at each tirzepatide dose level, with a ~1.6-fold accumulation ratio.
R re-titration clinical guidance
Restarting at a lower dose after a treatment pause longer than 4 weeks. GI tolerance can be lost during pauses, and resuming at the prior maintenance dose risks severe nausea and vomiting.